Advanced search
Publication Cover
Acta Oncologica Volume 62, 2023 - Issue 9
Journal homepage
221
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Cancer Epidemiology

Evaluation of statin use and renal cell carcinoma risk identifies sex-specific associations with RCC subtypes

Irmina Maria Michaleka Department of Pathology, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Warsaw, Poland;b Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USAORCID Iconhttps://orcid.org/0000-0001-8367-5916View further author information
ORCID Icon,
Rebecca E. Graffb Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA;c Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USAView further author information
,
Alejandro Sanchezd Division of Urology, Department of Surgery, Huntsman Cancer Institute and University of Utah, Salt Lake City, UT, USAView further author information
,
Toni K. Choueirie Department of Medical Oncology, Dana-Farber Cancer Institute, The Lank Center for Genitourinary Oncology, Boston, MA, USAView further author information
,
Eunyoung Chof Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA;g Department of Dermatology, The Warren Alpert Medical School of Brown University, Providence, RI, USA;h Department of Epidemiology, Brown University School of Public Health, Providence, RI, USAView further author information
,
Mark A. Prestoni Division of Urology, Brigham and Women’s Hospital, Boston, MA, USACorrespondence[email protected]
View further author information
&
Kathryn M. Wilsonc Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA;f Channing Division of Network Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USAView further author information
 show all
Pages 988-993 | Received 20 May 2023, Accepted 11 Jul 2023, Published online: 23 Jul 2023

References

  • Apostolova SN, Toshkova RA, Momchilova AB, et al. Statins and alkylphospholipids as new anticancer agents targeting lipid metabolism. Anticancer Agents Med Chem. 2016;16(12):1512–1522.
  • Demierre MF, Higgins PD, Gruber SB, et al. Statins and cancer prevention. Nat Rev Cancer. 2005;5(12):930–942. doi:10.1038/nrc1751.
  • Brown M, Hart C, Tawadros T, et al. The differential effects of statins on the metastatic behaviour of prostate cancer. Br J Cancer. 2012;106(10):1689–1696. doi:10.1038/bjc.2012.138.
  • Bjarnadottir O, Romero Q, Bendahl PO, et al. Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial. Breast Cancer Res Treat. 2013;138(2):499–508. doi:10.1007/s10549-013-2473-6.
  • Khurana V, Caldito G, Ankem M. Statins might reduce risk of renal cell carcinoma in humans: case-control study of 500,000 veterans. Urology. 2008;71(1):118–122. doi:10.1016/j.urology.2007.08.039.
  • Pottegard A, Clark P, Friis S, et al. Long-term use of statins and risk of renal cell carcinoma: a population-based case-control study. Eur Urol. 2016;69(5):877–882. doi:10.1016/j.eururo.2015.10.020.
  • Chiu HF, Kuo CC, Kuo HW, et al. Statin use and the risk of kidney cancer: a population-based case-control study. Expert Opin Drug Saf. 2012;11(4):543–549. doi:10.1517/14740338.2012.678831.
  • Kang M, Ku JH, Kwak C, et al. Effects of aspirin, nonsteroidal anti-inflammatory drugs, statin, and COX2 inhibitor on the developments of urological malignancies: a population-based study with 10-year follow-up data in Korea. Cancer Res Treat. 2018;50(3):984–991. doi:10.4143/crt.2017.248.
  • Liu W, Choueiri TK, Cho E. Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts. Cancer. 2012;118(3):797–803. doi:10.1002/cncr.26338.
  • Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol. 1984;119(5):837–839. doi:10.1093/oxfordjournals.aje.a113804.
  • Percy CV, Muir C. International classification of disease for oncology. 2nd ed. Geneva (Switzerland): World Health Organization; 1990.
  • Puckett CD. The educational annotation of ICD-9-CM. Reno (NV): Channel Publishing Ltd.; 1986.
  • Cox DR. Regression models and life-tables. In: Kotz S, Johnson NL, eds. Breakthroughs in statistics: methodology and distribution. New York (NY): Springer New York; 1992. p. 527–541.
  • Rider JR. Trouble in paradise: unmeasured confounding in registry-based studies of etiologic factors. Eur Urol. 2016;69(5):883–884. doi:10.1016/j.eururo.2015.10.044.
  • Scelo G, Li P, Chanudet E, et al. Variability of sex disparities in cancer incidence over 30 years: the striking case of kidney cancer. Eur Urol Focus. 2018;4(4):586–590. doi:10.1016/j.euf.2017.01.006.
  • Graff RE, Sanchez A, Tobias DK, et al. Type 2 diabetes in relation to the risk of renal cell carcinoma among men and women in two large prospective cohort studies. Diabetes Care. 2018;41(7):1432–1437. doi:10.2337/dc17-2518.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.